 |
 |

School-Based Clusters of Meningococcal Disease in the United StatesDescriptive Epidemiology and a Case-Control Analysis
Kenneth M. Zangwill, MD;
Anne Schuchat, MD;
Francis X. Riedo, MD;
Robert W. Pinner, MD;
Denise T. Koo, MD, MPH;
Michael W. Reeves, PhD;
Jay D. Wenger, MD
JAMA. 1997;277(5):389-395.
Abstract
 |  |
Objective. —To evaluate the epidemiologic features and risk factors for multiple cases of meningococcal disease in schools.
Design. —Population-based prospective evaluation and case-control study of clusters of meningococcal disease that occurred in schools from January 1989 to June 1994.
Setting. —Surveillance conducted through state health departments in the United States.
Main Outcome Measures. —Descriptive epidemiology of school-based clusters of meningococcal disease and determinants of their occurrence.
Results. —We identified 22 clusters of meningococcal disease in 15 states. The estimated incidence of secondary meningococcal disease among schoolchildren aged 5 to 18 years was 2.5 per 100 000 population, a relative risk of 2.3 (95% confidence interval [CI], 1.6-3.3). The median number of students per cluster was 2 (range, 2-4). Of 30 subsequent cases, 10 (33%) occurred 2 or fewer days after the index case, and 22 (73%) occurred 14 or fewer days after the index case. Among the 8 schools with 2 or more cases, 50% of the additional cases occurred 2 or more days after the second case. Secondary schools (grades 7 through 12) accounted for 15 (75%) of 20 cluster schools compared with 9 (45%) of 20 matched control schools (P<.05). In 16 (73%) of 22 clusters, interaction between case patients was noted. The index patient in cluster schools was more likely than the controls to have participated in a school-based group activity 14 or fewer days before illness (matched odds ratio, 7.0; 95% CI, 0.9-57).
Conclusions. —Three quarters of the school clusters occurred in secondary schools, with over 70% of subsequent cases occurring within 2 weeks of the index case. Rapid initiation of a chemoprophylaxis program after 2 cases of meningococcal disease in a school would have potentially prevented 50% of subsequent cases in the clusters described.
Author Affiliations
From the Childhood and Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, Ga (Drs Zangwill, Schuchat, Riedo, Pinner, Koo, Reeves, and Wenger). Dr Zangwill is now with the Harbor-UCLA Medical Center, UCLA Center for Vaccine Research, UCLA School of Medicine, Los Angeles, Calif. Dr Riedo is now with the Department of Medicine, University of Washington Medical School, Seattle. Dr Pinner is now with the National Center for Infectious Diseases at CDC. Dr Koo is now with the Epidemiology Program Office at CDC. Dr Wenger is now with the World Health Organization, Geneva, Switzerland.
Footnotes
Corresponding author: Anne Schuchat, MD, Childhood and Respiratory Diseases Branch, National Center for Infectious Diseases, Mailstop C-09, Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Molecular Epidemiology of Neisseria meningitidis Isolates from an Outbreak of Meningococcal Disease among Men Who Have Sex with Men, Chicago, Illinois, 2003
Schmink et al.
J. Clin. Microbiol. 2007;45:3768-3770.
ABSTRACT
| FULL TEXT
Evidence for Indirect Nosocomial Transmission of Neisseria meningitidis Resulting in Two Cases of Invasive Meningococcal Disease
Elias et al.
J. Clin. Microbiol. 2006;44:4276-4278.
ABSTRACT
| FULL TEXT
Prevention of Meningococcal Disease
Gardner
NEJM 2006;355:1466-1473.
FULL TEXT
Prospects for Vaccine Prevention of Meningococcal Infection
Harrison
Clin. Microbiol. Rev. 2006;19:142-164.
ABSTRACT
| FULL TEXT
Clusters of meningococcal disease in school and preschool settings in England and Wales: what is the risk?
Davison et al.
Arch. Dis. Child. 2004;89:256-260.
ABSTRACT
| FULL TEXT
How Contagious Are Common Respiratory Tract Infections?
Musher
NEJM 2003;348:1256-1266.
FULL TEXT
Antibiotic Treatment of Children With Unsuspected Meningococcal Disease
Wang et al.
Arch Pediatr Adolesc Med 2000;154:556-560.
ABSTRACT
| FULL TEXT
Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management
van Deuren et al.
Clin. Microbiol. Rev. 2000;13:144-166.
ABSTRACT
| FULL TEXT
Meningococcal Disease and Public Health Practice: A Complicated Road Map
Moore and Osterholm
JAMA 1998;279:472-473.
FULL TEXT
|